J Biol Chem, Vol. 275, Issue 20, 15407-15412, May 19, 2000
Estrogen-modulated Estrogen Receptor·Pit-1 Protein Complex
Formation and Prolactin Gene Activation Require Novel Protein
Synthesis*
Chingwen
Ying
and
Don-Hei
Lin
From the Department of Microbiology, Soochow University, Taipei,
Taiwan 111, Republic of China
Both estrogen receptor (ER) and Pit-1 proteins
are essential for the estrogen-activated expression of the rat
prolactin gene. Our results show that ER·Pit-1 protein complex
formation is reduced by estrogen in GH3 and PR1 rat pituitary tumor
cells. In the latter, this decrease was blocked by cycloheximide, a
protein synthesis inhibitor. On the other hand, the direct addition of
estrogen to PR1 cell lysates had no effect on the formation of
ER·Pit-1 complexes. Estrogen-activated prolactin gene expression was
also inhibited by cycloheximide, suggesting that some form of protein synthesis is involved in ER·Pit-1 complex formation and subsequent prolactin gene activation. In support of this notion, we showed that
estrogen-induced regulation of ER·Pit-1 complex formation could be
transferred from cell lysates prepared from estrogen-treated PR1 cells
to control cell lysates. This is not true for GH3 cells; instead,
direct administration of estrogen to GH3 cell lysates readily abolished
ER·Pit-1 protein complex formation in a dose-dependent manner, and such estrogen-induced regulation was blocked by the antiestrogen ICI 182,780. These findings thus indicate that 1) interaction between ER and Pit-1 proteins is estrogen-regulated in ways
specific to different cell types, and 2) auxiliary protein factor
synthesis may be involved in this process.
*
This work was supported in part by National Science Council
Grant 84-2311-B-031-002.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.